애널리스트 20명 기준
목표가는 개별 리서치펌 단위가 아닌 시장 컨센서스(평균/최고/최저)입니다. 수집 액션 40건 · 최근 12개월 40건.
| 날짜 | 리서치펌 | 애널리스트 | 액션 | 의견 변화 | 목표가 | 리포트 |
|---|---|---|---|---|---|---|
| 2026. 04. 28. | Mizuho | — | 의견 유지 | Outperform → Outperform | — | Mizuho: Outperform |
| 2026. 04. 28. | UBS | — | 의견 유지 | Buy → Buy | — | UBS: Buy |
| 2026. 04. 25. | Barclays | — | 의견 유지 | Overweight → Overweight | — | Barclays: Overweight |
| 2026. 04. 15. | B of A Securities | — | 의견 유지 | Neutral → Neutral | — | B of A Securities: Neutral |
| 2026. 04. 09. | Wells Fargo | — | 의견 유지 | Overweight → Overweight | — | Wells Fargo: Overweight |
| 2026. 04. 09. | Cantor Fitzgerald | — | 의견 유지 | Overweight → Overweight | — | Cantor Fitzgerald: Overweight |
| 2026. 04. 09. | Barclays | — | 의견 유지 | Overweight → Overweight | — | Barclays: Overweight |
| 2026. 03. 31. | Keefe, Bruyette & Woods | — | 투자의견 하향 | Outperform → Market Perform | — | Keefe, Bruyette & Woods: Outperform → Market Perform |
| 2026. 02. 05. | Keefe, Bruyette & Woods | — | 의견 유지 | Outperform → Outperform | — | Keefe, Bruyette & Woods: Outperform |
| 2026. 02. 05. | Citigroup | — | 의견 유지 | Neutral → Neutral | — | Citigroup: Neutral |
| 2026. 02. 04. | Morgan Stanley | — | 의견 유지 | Equal-Weight → Equal-Weight | — | Morgan Stanley: Equal-Weight |
| 2026. 02. 03. | UBS | — | 의견 유지 | Buy → Buy | — | UBS: Buy |
| 2026. 02. 03. | Cantor Fitzgerald | — | 의견 유지 | Overweight → Overweight | — | Cantor Fitzgerald: Overweight |
| 2026. 02. 03. | Wells Fargo | — | 의견 유지 | Overweight → Overweight | — | Wells Fargo: Overweight |
| 2026. 01. 31. | Roth Capital | — | 의견 유지 | Neutral → Neutral | — | Roth Capital: Neutral |
| 2026. 01. 14. | Cantor Fitzgerald | — | 의견 유지 | Overweight → Overweight | — | Cantor Fitzgerald: Overweight |
| 2026. 01. 13. | Wells Fargo | — | 의견 유지 | Overweight → Overweight | — | Wells Fargo: Overweight |
| 2026. 01. 08. | Evercore ISI Group | — | 의견 유지 | In-Line → In-Line | — | Evercore ISI Group: In-Line |
| 2026. 01. 08. | JP Morgan | — | 의견 유지 | Neutral → Neutral | — | JP Morgan: Neutral |
| 2026. 01. 07. | Keefe, Bruyette & Woods | — | 의견 유지 | Outperform → Outperform | — | Keefe, Bruyette & Woods: Outperform |
| 2025. 12. 22. | Piper Sandler | — | 의견 유지 | Overweight → Overweight | — | Piper Sandler: Overweight |
| 2025. 12. 16. | Mizuho | — | 커버리지 개시 | — → Outperform | — | Mizuho: Outperform |
| 2025. 12. 08. | UBS | — | 의견 유지 | Buy → Buy | — | UBS: Buy |
| 2025. 11. 26. | Argus Research | — | 의견 유지 | Buy → Buy | — | Argus Research: Buy |
| 2025. 11. 18. | Morgan Stanley | — | 의견 유지 | Equal-Weight → Equal-Weight | — | Morgan Stanley: Equal-Weight |
| 2025. 11. 04. | Keefe, Bruyette & Woods | — | 의견 유지 | Outperform → Outperform | — | Keefe, Bruyette & Woods: Outperform |
| 2025. 10. 29. | Wells Fargo | — | 의견 유지 | Overweight → Overweight | — | Wells Fargo: Overweight |
| 2025. 10. 09. | JP Morgan | — | 의견 유지 | Neutral → Neutral | — | JP Morgan: Neutral |
| 2025. 10. 09. | UBS | — | 의견 유지 | Buy → Buy | — | UBS: Buy |
| 2025. 10. 08. | Wells Fargo | — | 의견 유지 | Overweight → Overweight | — | Wells Fargo: Overweight |
| 2025. 10. 07. | Morgan Stanley | — | 의견 유지 | Equal-Weight → Equal-Weight | — | Morgan Stanley: Equal-Weight |
| 2025. 10. 02. | Evercore ISI Group | — | 의견 유지 | In-Line → In-Line | — | Evercore ISI Group: In-Line |
| 2025. 09. 16. | Wolfe Research | — | 커버리지 개시 | — → Peer Perform | — | Wolfe Research: Peer Perform |
| 2025. 09. 02. | Piper Sandler | — | 의견 유지 | Overweight → Overweight | — | Piper Sandler: Overweight |
| 2025. 08. 13. | Citigroup | — | 커버리지 개시 | — → Neutral | — | Citigroup: Neutral |
| 2025. 08. 05. | Keefe, Bruyette & Woods | — | 의견 유지 | Outperform → Outperform | — | Keefe, Bruyette & Woods: Outperform |
| 2025. 08. 04. | UBS | — | 의견 유지 | Buy → Buy | — | UBS: Buy |
| 2025. 08. 01. | Raymond James | — | 의견 유지 | Outperform → Outperform | — | Raymond James: Outperform |
| 2025. 07. 31. | Morgan Stanley | — | 의견 유지 | Equal-Weight → Equal-Weight | — | Morgan Stanley: Equal-Weight |
| 2025. 07. 30. | Wells Fargo | — | 의견 유지 | Overweight → Overweight | — | Wells Fargo: Overweight |